Skip to content

Next government will amend the Drugs Act: Toshima Karki

Kalopati

56 minutes ago

Kathmandu. Dr Toshima Karki, a lawmaker elected from Lalitpur Constituency-3 on the Rastriya Swatantra Party (RSP), has expressed confidence that the new government would emphatically amend the Drugs Act.

Speaking at the Nepal Pharma Expo and interaction programme on ‘Self-reliance in Medicines: Policy Questions’ organized in the capital on Tuesday, Minister Bhandari said that it was not possible to provide modern and timely medical services with the 47-year-old Drugs Act.

“The government cannot guarantee that we can provide timely medical treatment with the 47-year-old Drug Act,” she said. Therefore, the next government will amend this Act on priority. ’

He said that the lack of willpower and unethical games are the reason behind the simple issues of the health sector. He claimed that the RSP government would play the role of a servant government in the health sector.

“Lack of willpower and unethical games are the reason why even simple issues in the health sector are stuck till date. When the leadership works with the power of morality, then all these problems are solved. The next government of the RSP will play the role of a servant government in the health sector,” she said.

“Self-sufficiency in medicines is not only a commercial issue but also a sensitive issue related to the security of the citizens,” she said. “Every citizen should have access to affordable, affordable and quality medicines,” she said, stressing that the State should ensure the same.

“Self-sufficiency in medicine is not just a business aspect. This is an issue related to the safety of the citizens. Every citizen should have access to affordable, affordable and quality medicines. This should be ensured by the state. Since it is a sensitive aspect, it is not allowed to be seen only as a trade and business. ’

According to him, it is not enough to test the quality of the medicine only while producing it, but it is also necessary to monitor whether the quality of the medicine is maintained till the time the patient consumes it.

“There is a need for quality testing and effective regulation in all processes from storage to distribution of medicines,” she said.

Leave your comment